Supplemental Table for RAAS inhibitors and keratinocyte carcinoma risk: a TriNetX new-user, active-comparator cohort study

Published: 19 January 2026| Version 2 | DOI: 10.17632/j87nm4hjxz.2
Contributor:
Nuran Golbasi

Description

Supplementary Appendix

Files

Categories

Basal Cell Carcinoma, Squamous Cell Carcinoma, Database

Licence